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6Abstract 
Objective: The primary objective of this study was to test the long-term (6 months) efficacy 
of an Internet- and mobile-based smoking cessation programme. 
Design: A two-armed randomized control trial. Participants surveyed at baseline and 3-days 
pre-cessation, and 1, 3, and 6 months post-cessation. 
Setting: Norway. The study and the experimental condition occurred via the Internet and 
mobile-phone. The control condition received self-help booklets through the postal mail 
service. 
Participants: A total of 427 eligible participants were assessed of which 290 were included in 
the study. Participants were treatment seeking smokers recruited online through local and 
regional covering newspapers. All participants were above the age of 18, had daily access to 
the Internet and a mobile phone, and currently smoking five cigarettes or more on a daily 
basis. 
Methods: The Internet- and mobile phone-based intervention consists of image- and text-
based websites containing different educational components. The purpose of the mobile 
phone is to support the activities and processes initiated through the web with some additional 
features. The control condition received a self-help booklet. Online self-report measures were 
used to collect data with no biochemical verification while email reminders and telephone 
interviews were conducted as follow-up. The primary outcome measure was 7-days 
abstinence at 6 months. Secondary outcomes included 7-days abstinence at 1 and 3 months. 
Results: Using an intent-to-treat analysis, more participants in the experimental condition had 
quit smoking compared to the control group at 6 months: 42 (29%) vs. 20 (14%), odds ratio = 
2.59 (95% confidence intervals: 1.43 - 4.69.), p = .002. The treatment effect was also present 
at 1 (odds ratio = 3.46, 95% confidence intervals: 2.01 - 5.95) and 3 months (odds ratio = 
2.93, 95% confidence intervals: 1.67 - 5.14). 
Conclusions: These results suggest that a smoking cessation programme can be successfully 
delivered via the Internet and mobile-phone. 
Keywords: Smoking cessation, randomized control trial, Internet, mobile phone, self-efficacy, 
coping planning.
71 Introduction
1.1    Smoking Attributable Mortality and Health Consequences 
Smoking is identified as the second most leading risk factor in the burden of premature 
mortality and morbidity (World Health Organization [WHO], 2002, 2007). Simultaneously, it 
is the most preventable cause of mortality because of the lag between smoking onset and 
disease occurrence (U.S. Department of Health and Human Services, 2004; WHO, 2002). 
Hazards associated with smoking can be almost completely avoided if cessation occurs at the 
age of 30 and halved at the age of 50 (Doll, Peto, Boreham & Sutherland, 2004). Therefore, 
smoking cessation alone is likely to yield a reduction in mortality. 
Annually, about 30% (440 000) of the U.S. death toll is attributable to smoking (Centers for 
Disease Control and Prevention [CDCP], 2002, 2005). Each American person who die of 
smoking lose on average 13 years of potential life expectancy which amounts to a total of 5.5 
million years of life lost in the U.S. (CDCP, 2005). In Europe smoking accounts for 12% of 
total years of life lost due to premature mortality and years lived in disability (WHO, 2002, 
2007). This equates to about 18.6 million years of life lost. In comparison, Vollset, Selmer, 
Tverdal and Gjessing (2006) estimated that smoking accounted for 16% (6,700) of all deaths 
in Norway in 2003. On average, each person who died of smoking lost 11 years of potential 
life expectancy which amounts to 72,000 years of life lost. Moreover, more than half of the 
global smoking attributable mortality occurs between the ages 30 to 69 years (Ezzati & 
Lopez, 2003; Peto, Lopez, Boreham, Thun & Heath, 1992). It is estimated that these middle-
aged women and men lose on average 23 years of potential life expectancy (Peto et al., 1992). 
In comparison, 40% of Norwegian deaths among middle-aged (40 to 70 years of age) women 
and men is attributable to smoking (Vollset, Selmer et al., 2006; Vollset, Tverdal & Gjessing, 
2006). 
Smokers as compared to never smokers are at a significantly elevated risk for death due to 
coronary heart diseases, chronic obstructive pulmonary diseases, all types of strokes, other 
arterial diseases, lung cancer, and other types of cancers (Danaei et al. 2005; Ezzati & Lopez, 
2003; Jacobs et al. 1999; for overview, see; Fagerström, 2002). In Norway, for example; 18% 
(1,900) of cancers, 18% (3,200) of coronary heart diseases, and 29% (1,300) of respiratory 
diseases in 2001 were attributable to smoking (Sanner, 2005, for examples, see; Humerfelt & 
Gulsvik, 1995; Tverdal, 1995; Vollset, Tverdal et al., 2006). Additionally, exposures of 
environmental tobacco smoke causes premature death and diseases in children and adults who 
8do not smoke, e.g. slow lung growth in children, sudden infant death syndrome, acute 
respiratory infections, and severe asthma (Dybing & Sanner, 1999; U.S. Department of Health 
and Human Services, 2006). In Norway it is estimated that 300 to 500 non-smokers die due to 
heart disease (Dybing & Sanner, 1995) and that 50 non-smokers die due to lung cancer caused 
by passive smoking (Sanner & Dybing, 1996; Norwegian Directorate for Health and Social 
Affairs, 2003). As if that was not enough, smoking must also be considered an important risk 
factor for the prognosis and development of diseases which are not causally related, e.g. 
dermatological changes, diabetes, gastric ulcer, including more (Haustein, 2003). 
1.2    Smoking Prevalence and Behavioural Intentions
About 24% of the Norwegian population aged 16 to 74 are daily smokers and 10% report 
being occasional smokers (Statistics Norway, 2007). In perspective, the mean population-
weighted smoking prevalence rate in Europe is 29% (WHO, 2007) which includes 18% 
smokers among females and 40% smokers among males. In Norway, there are no gender 
differences in smoking prevalence, but there are nearly three times as high a proportion of 
smokers with compulsory education as compared to the proportion of smokers with a college 
or university education. A similar gap exists in smoking prevalence between smokers with 
higher education and smokers with lower education in Europe. The gap is especially 
accentuated in the western part of the European region (e.g. Ireland, France, and Iceland). 
Norwegian smokers who have only completed compulsory education are overrepresented 
among daily smokers which have not made a quit attempt the last year, that have no intentions 
of quitting the next 6 months, and which have a future identity as a smoker (Lund, Lund & 
Rise, 2005). Alongside heavy smokers, smokers who started smoking early, and smokers who 
use hand-rolled tobacco, they are the least interested in quitting (Lund & Lund, 2005; Lund, 
Lund & Rise, 2005). They have fewer future perspectives on quit activity, fewer restrictions 
for indoors smoking at home, and are less informed about existing professional assistance 
(Lund, Lund & Rise, 2005). 
Among all Norwegian smokers, approximately 80% report having attempted to quit 
smoking sometime, 44% report intentions to quit within the next 6 months, whereas 11% 
report intentions to quit within the next 30 days (Norwegian Directorate for Health and Social 
Affairs [NDHSA], 2004). Thus, it seems fair to say many Norwegian smokers are motivated 
to quit. However, behaviour change does not necessarily follow good intentions (Sheeran, 
Webb & Gollwitzer, 2005). Figures are ranging from 20% (NDHSA, 2004) to 30% (Kraft, 
Svendsen & Hauknes, 1998) for those who actually made a quit attempt the last 12 months. 
9This shows that the traditional behaviour-intention gap is at the very utmost prevailing in 
relation to smoking cessation (for examples, see; Moan & Rise, 2005; Norman, Connor & 
Bell, 1999). The behaviour-intention gap most likely reflects that smokers have difficulties 
anticipating their actual control over quitting smoking and highlights the need for assistance. 
1.3    Smoking Cessation
Abstinent rates above 30% are rare even among cost-intensive interventions that usually are 
the most effective as designed by professionals (Fiore et al., 2000). However, the majorities of 
those who attempt quitting do so without any professional assistance at all. Only one in five 
who attempted to quit smoking the past 12 months reported having used assistance 
(Cokkinides, Ward, Jemal & Thun, 2005; Zhu, Melcer, Sun, Rosbrook & Pierce, 2000). 
Among Norwegian ex-smokers, the reported use of assistance in relation to their last 
successful quit attempt was rather low. Only 10%, 7%, and 5% reported using nicotine gum, 
nicotine patch, or seeking advice from health professionals respectively (NDHSA, 2004). The 
problem with discarding professional assistance is that most unaided quitters relapse within 6-
12 months (Fiore et al. 2000; Hughes, Keely & Naud, 2004; Ward, Klesges, Zbikowski, Bliss 
& Garvey, 1997). Normally about 50% relapse within the first two weeks, 65% within the 
first month, and 92% within four months (NDHSA, 2004). This equals a successful long-term 
cessation rate less than 1 to 10. Even long-term abstinence rates as low as three to five percent 
has been reported (Hughes et al. 2004). 
Clearly, professional assistance is not being utilized to its full potential, but nevertheless, 
smokers report a certain preference for self-help materials and counselling (Cunningham, 
Ferrence, Cohen & Adlaf, 2003; Spoth, 1991; Ussher, West & Hibbs, 2004; Zhu et al., 2000). 
Self-help includes a wide range of materials and supplements like books, booklets, social 
support, telephone counselling, audio-, and videotapes. They are commonly inexpensive to 
deliver and can be disseminated at a large scale in the population. Self-help materials are 
possibly better than no intervention at all, but they are not especially effective in most cases 
(Lancaster & Stead, 2005a). Hence, they are only to be considered cost-effective given that 
they have a treatment effect.
The most widely used therapeutic treatments often combine cognitive therapy and 
behavioural skills training which can be delivered individually or in a group. In both cases, 
individual behavioural counselling (Lancaster & Stead, 2005b) and group behavioural therapy 
(Stead & Lancaster, 2005) can effectively assist smokers to quit. However, the drawbacks of 
counselling are (a) the time it consumes, (b) the physical boundaries of space, and (c) the 
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expenses related to treatment. Additionally, counselling lacks the immediacy of help when 
encountering critical situations or experiencing withdrawal symptoms as is possible to offer 
through information and communication technology (ICT).   
1.4    Information and Communication Technology Interventions
In contrast to behavioural counselling, technology has the potential to reach many smokers at 
a low cost and to mimic the transactional qualities of human communication (Cassell, Jackson 
& Cheuvront, 1998), e.g. imitate behavioural therapy. Psychological theory, models, and 
therapy combined with the Internet and mobile-phone technology can be an effective method 
for disseminating knowledge and materials at a population level. Several studies suggest that 
computer-based smoking cessation programmes (for examples, see; Etter, 2005; Lenert et al. 
2003; Strecher, Shiffman & West, 2005; Swartz, Noell, Schroeder & Ary, 2006) and text 
messaging (Rodgers et al. 2005) are effective, but few studies have examined the long-term 
outcomes [defined as 6 months or longer (Etter, 2006; for example, see; Munoz et al. 2006)]. 
Strecher (1999) reviewed ten first generation computer-based smoking cessation 
interventions which refer to (a) collecting individual characteristics relevant to smoking 
cessation, (b) a computer algorithm that uses the collected data and generates a tailored 
message to the specific needs of the user, and (c) feedback delivered in paper format. Six out 
of nine studies offered evidence supporting the effect of computer-based tailored materials 
and one study found partially positive effects. More recently Walters, Wright & Shegog 
(2006) reviewed digitally delivered smoking cessation interventions and identified 19 studies 
of which nine showed improved outcomes as compared to control conditions. Both Strecher 
(1999) and Walters et al. (2006) found few consistent patterns or intervention characteristics 
which led to positive outcomes. But it was suggested that tailored computer-based materials 
(Strecher, 1999) and theoretically-based interventions (Walters et al.) are likely to be more 
effective. 
The present study was set to evaluate one such ICT-based intervention with a theoretical 
foundation. A problem at the current moment with ICT-based smoking cessation research is
that studies do not usually report on what theoretical basis the intervention was designed, how 
psychological constructs were attempted to manipulate, and so forth. Under such conditions, it 
becomes very difficult for other researchers and health professionals to learn from research. 
Therefore, the following describes the theory and research that was used to design Happy
Ending, i.e. how Happy Ending combines Internet- and mobile-based technology to deliver 
self-help management materials, cognitive-behavioural counselling, and relapse prevention. 
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2 The Theoretical Background of Happy Ending
Happy Ending (HE) is a digitally delivered and fully automated Internet- and mobile phone-
based smoking cessation programme based on psychological research. It is intended for 
individual behaviour change across genders, all ages, educational levels, etc. Rothman (2000; 
Rothman, Baldwin & Hertel, 2004) argues for the distinction of the processes or decision 
criteria underlying behaviour initiation, behaviour maintenance and habit formation. The 
implications are such that interventions aiming at the different distinct processes have to apply 
different programme elements. Interventions aiming at behaviour initiation should maybe 
focus on motivation while interventions aiming at maintenance and habit formation should 
focus on aiding quitters in performing and controlling behaviour. Because Happy Ending 
concerns behavioural maintenance and habit formation, Happy Ending is specifically 
designed for smokers already motivated to quit to assist performing, maintaining, and forming
a new and healthy habit. 
2.1    The Preparation Phase
Happy Ending (HE) begins with a 14 days preparation phase. The client receives an email 
every morning with a link to an external website. There is a unique website every day which 
the client has access to only that specific day. The reason for this strict regimen is because HE 
is constructed on the basis of a reasoned chronology. The chronology is modelled according 
to the psychological processes smokers experience at different points in the process of 
smoking cessation (Brandon, Tiffany, Obremski & Baker, 1990; Gilbert & Warburton, 2003; 
Lichtenstein & Glasgow, 1992; Piasecki, Fiore & Baker, 1998; Piasecki, Fiore, McCarthy & 
Baker, 2002; Piasecki, Jorenby, Smith, Fiore & Baker, 2003a, 2003b, 2003c; Shiffman, 2005; 
Shiffman, Paty, Gnys, Kassel & Hickcox, 1996; Shiffman & Waters, 2004; Kenford et al., 
2002; Ockene et al., 2000; Piasecki et al., 2000; Shiffman, Hickcox et al., 1996; Shiffman et 
al., 1997). 
For such reasons, the client spends the first few days in the programme building a 
therapeutic alliance and confidence in the treatment provider. These are just two of the ground 
rules of cognitive-behavioural therapy (for overview, see; Berge & Repål, 2005) which HE 
aims at establishing early. In addition, it is fundamental for positive outcomes in treatment
that the client gets engaged and involved in his or her own process of smoking cessation. This 
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means the client must understand the procedure during treatment, the most important 
concepts, and appreciate how our thoughts can influence our emotions. 
One of the first concepts the client learn about is self-monitoring. Self-monitoring is a 
self-regulatory tool to help the client not only become consciously aware of their own 
behaviour, but help him or her get actively engaged and involved (Baumeister & Heatherton, 
1996; Baumeister, Heatherton & Tice; 1994). Violation to the principle of self-monitoring can 
result in disengagement and break the dose-response relationship between treatment intensity 
and probability of positive outcomes (Lancaster & Stead, 2004; Silagy, Lancaster, Stead, 
Mant & Fowler, 2004; West, McNeill & Raw, 2000; Ockene et al., 1994). 
A second concept is self-efficacy which is an important determinant for the outcome of 
self-change processes (Bandura, 1977). Self-perception of efficacy influence people’s 
cognitions, behaviour, and emotional arousal and refer to people’s beliefs in their own 
capability to exercise control over the events that affect their lives (Bandura, 1982, 1989). 
Pre- and post-cessation self-efficacy has both been shown to play an important role in relation 
to smoking cessation (Schwarzer & Fuchs, 1995; for examples, see; Condiotte & Lichtenstein, 
1981; Stuart, Borland & McMurray, 1994). As a general rule, the belief and confidence in the 
person’s own ability to change should be high, but not overly optimistic or unrealistic. 
Unrealistically high self-efficacy can cause transgressions to affect the person negatively 
(Schwarzer & Fuchs, 1995). 
Besides learning about important concepts, HE contains web-based activities (e.g. 
problem-solving tasks, cognitive and emotional tasks, writing an interactive personal diary) 
and information where the client learns about his or her psychological profile and responses 
as a person and as a smoker. The client learns about his or her past smoking behaviour, 
nicotine dependence, past quit failures, motivational basis for quitting, problems often 
experienced when quitting, stress and weight regulation, the use of nicotine replacement 
therapy, and more. There is especially one important psycho-educational component which 
addresses the issue of lapses, i.e. smoking a few cigarettes during a quit attempt, and relapse, 
i.e. returning to past smoking behaviour. The client learns that it is completely normal to 
experience one or several lapses (Hughes et al., 2004; Piasecki et al., 2002). It is not critical 
whether a client experiences a lapse or two, but how the client reacts cognitively, affectively, 
and behaviourally. The purpose is to prevent the devastating consequences of zero-tolerance 
beliefs (Baumeister et al. 1994) and to prevent minor transgressions to cause a full-blown 
relapse (Larimer, Palmer & Marlatt, 1999; Marlatt & Gordon, 1985). The client prepares for 
these reactions in case of a lapse, becomes enabled to recognize the reactions when they 
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occur, and acquires specific skills and support systems to master lapses. Hence, the 
probability for successful self-regulation should increase significantly (Baumeister et al.). 
In addition to the websites, HE communicates via the mobile phone and interactive voice 
response (IVR; phone technology that typically allows a person to select options from a voice 
menu and interact with the phone system). The purpose is twofold. First, the client must get 
acquainted with and used to communicating with HE via the mobile phone. The mobile phone 
will play a crucial role later during the action and maintenance phase in the programme. 
Second, the mobile phone is used to support the activities and processes initiated through the 
websites. The two-way communication will also ensure active participation on behalf of the 
client, as well as it will give the perception of individualization in the follow-up of the 
programme. 
2.2    The Action Phase
Upon completing the preparation phase, the client enters a 30 days action phase. Up to this 
point the client has been smoking his or her usual amount of daily cigarettes. What happens 
now is that the client stops smoking completely. During this phase further activities and 
processes are initiated through the websites to ensure active participation and involvement. 
Hence, there are numerous contact points between the client and HE each day at an even 
increased intensity and frequency than previously (minimum four contact points via the 
mobile phone). 
One of the first expected difficulties to arise is a shift in the motivational basis for quitting 
(Gilbert & Warburton, 2003; Rothman, 2000; Rothman et al. 2004). In particular, the loss of 
positive short-term consequences of smoking (e.g. becoming relaxed, less irritable) tend to 
become pronounced while the importance of positive long-term outcomes (e.g. reduced risk 
for coronary heart disease, reduced risk for cancer) tend to become deflated (Gilbert & 
Warburton, 2003). To prevent changes in motivational basis, HE provides a type of 
biofeedback about the positive consequences of quitting (e.g. normalization of body 
temperature, reduced risk for catching a cold, drop in blood pressure equivalent to that of a 
non-smoker). The client receives these messages via the mobile phone using IVR. 
Other expected difficulties to occur are changes in self-efficacy, changes in affect, and the 
encounter of high-risk situations. First, an aim in the programme is to strengthen the post-
cessational self-efficacy as it has been identified as a key predictor for the outcome of a 
smoking cessation attempt (Condiotte & Lichtenstein, 1981; Gulliver, Hughes, Solomon & 
Dey, 1995; Schwarzer & Fuchs, 1995). More specifically, variations in self-efficacy have 
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been detected to occur prior to lapses and relapse (Dijkstra & Brosschot, 2003; Dijkstra & 
Wolde, 2005; Gwaltney, Shiffman, Balabanis & Paty, 2005; Shiffman, 2005; Shiffman et al., 
1997; Shiffman et al., 2000). To strengthen and stabilize post-cessational self-efficacy HE (a) 
reminds the client about the wide range of skills acquired and tools available to them, (b) 
prepares the client psychologically for tempting situations, and (c) encourages learning from 
mastery experience. 
Second, negative affect (e.g. frustration, anger, depression) has also been identified as a 
predictor of lapses and relapse (Shiffman, Paty et al., 1996; Shiffman & Waters, 2004). It has 
been detected to be increasing especially in the hours before lapses (Shiffman & Waters, 
2004). An affective model of drug motivation holds that affective states serve as stimuli for 
self-administration of drugs (Niaura et al., 1988) and it has been suggested that nicotine 
withdrawal symptomatology depends to a large extent on changes in negative affect (Piasecki, 
Kenford, Smith, Fiore & Baker, 1997). HE attempts to prevent negative affect by having 
available a Helpline which offers mood regulation and by sending encouraging messages 
telling the clients to e.g. reward their own accomplishments. 
Third, a very central element in the everyday activities in this phase is to have the client 
make explicit implementation intentions and coping planning regarding how to stay abstinent. 
This is done by giving the client small problem-solving tasks, cognitive and emotional tasks, 
and tasks that support reflection. In short, implementation intentions are specified goal-
directed responses to perform when encountering critical situations (Gollwitzer, 1999; 
Gollwitzer, Fujita & Oettingen, 2004) while coping planning refers to preparing coping 
strategies which will help prioritize the intended over the habitual in critical situations 
(Sniehotta, Scholz & Schwarzer, 2006). The former refers to behavioural coping strategies 
while the latter refers to cognitive coping strategies, and both are suggested as important 
mechanisms against relapse (for example, see; Gollwitzer et al., 2004; Sniehotta, Schwarzer, 
Scholz & Schuz, 2005). 
In the action phase, there is a log-on procedure every morning which means the client has 
to call HE. During this call, the client receives a confirmation that he or she is logged on and 
listens to a unique health message every day (e.g. what has happened to your health, 
appearance, breath). If the client does not log on, several text messages are automatically sent 
to the client’s mobile phone reminding him or her to log on. This is to assure active 
participation and self-monitoring so as to avoid that the client becomes psychologically 
remote in relation to the self-change process (Baumeister et al. 1994). 
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In the evening (between 8 p. m. and 11 p. m.) there is a log off procedure where HE calls 
the client. If the client does not answer, subsequent calls are attempted. If the client still does 
not answer, the client receives a text message reminding him or her to call HE and log off. 
The client reports if he or she has managed to stay abstinent during the day. If the client has 
been successfully abstinent, everything is going according to plans and there is no further 
need for change. On the other hand, if the client reports having smoked, regardless of how 
many cigarettes, a relapse prevention system is automatically activated. One of five different 
regimens may be activated depending on the number of lapses reported earlier in the 
programme. The purpose of each regime is to make the client attribute the lapse(s) as 
situational, thereby preventing lowered self-efficacy, negative affect, and eventually a relapse. 
The other purpose is to make the client accept the fact that a relapse is part of a deliberate 
decision and not something he or she is powerless to control or prevent. 
The relapse prevention system in HE is based upon the relapse proneness (RP) model as 
outlined by Piasecki et al. (2002). They prescribe a dynamic model of the natural history of 
the relapse process. According to the RP model, the first two weeks are characterized by 
physiological symptoms. These symptoms are primarily counter-reactions caused by the 
declining drug levels in the body. After the first couple of weeks at the demise of the 
physiological symptoms, the psychological symptoms become more pronounced. This phase 
is characterized by slow oscillations with occasional sudden and random bursts in relapse 
proneness. It is precisely during these sudden bursts in proneness a smoker is at the most 
vulnerable and most likely to experience a lapse or relapse. The last phase of the RP model is 
characterized by fatigue which is concurrent with self-regulatory strength in the self-
regulation model (Baumeister et al. 1994). Efforts requiring self-regulation taps the smoker of 
strength, and as a result, fatigue becomes an impediment for subsequent efforts of controlling 
behaviour (for overview, see; Muraven & Baumeister, 2000). 
In addition to considering the fact that a large proportion of quitters are likely to relapse, it 
is important to remember that a relapse typically follows a pattern of intermittent episodes of 
smoking (Ockene et al. 2000). Hence, an intervention should aim at restricting the amount of 
cigarettes smoked during lapses since this variable seems to predict the probability of later 
abstinence. After an initial lapse, a second lapse is very likely to occur often within one to 
four days (Brandon et al., 1990; Shiffman, Hickcox et al., 1996). Therefore, more effective 
smoking cessation interventions should be able to offer instant treatment to prevent the 
escalation of the process that promotes a following lapse or relapse, hence the log off 
procedure in HE. 
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The Helpline is another support system in HE which intends to offer instant help and 
which adds to the variety of different available tools. It is available to the client day and night 
throughout the entire programme from the onset of the action phase. The client is supposed to 
pre-program the number to the Helpline on their mobile phone to provide quick and easy 
access. Then, by specifying implementation intentions like ‘If I feel tempted to smoke a 
cigarette, I will call the Helpline’, the client might gain the necessary cognitive control over 
attention, thereby derailing the focus from the cravings. 
Whenever the client calls the Helpline, he or she is asked to specify what kind of help they 
need. There are three kinds of help; (a) support and mood regulation, (b) stress regulation, and 
(c) motivation to continue. The messages are constructed by professional psychologists and 
recorded by professional actors, containing a pool of 45 unique messages. Note that both the 
content and context of the therapeutic messages vary (e.g. testimonials, instructions given by 
a psychologist, doctor-patient conversations) It is worth noting that the message addresses the 
kind of help the client has specified and that the message is only indirectly related to smoking. 
What message the client receives is registered so as to avoid receiving the same message 
twice. The reasoned theory behind the Helpline is that it initially acts to create an attentional 
shift when making the call. Or else, increased self-awareness during acute pain or discomfort 
may actually increase the subjective perception of pain or discomfort (Baumeister, et al. 1994; 
Vohs & Schmeichel, 2003). Second, because cravings are episodic and relatively short lived
(Piasecki, 2006), a call to the Helpline may distract the quitter long enough for the cravings to 
have subdued. Third, the content of the message itself is of course intended to assist with the 
issue the client wishes to address (e.g. mood regulation). 
2.3    The Maintenance Phase
Finally, all clients are offered a maintenance phase which can last up to 11 months (optional 
duration). During the maintenance phase, the client no longer receives links to any websites. 
The log on procedure in the morning will shut down and the frequency of the log off 
procedure will be reduced in the upcoming weeks. The log off procedure continues 
immediately after the action phase daily for another month, twice a week for another two 
weeks, and then once a week for the remaining maintenance phase. The client will, however, 
remain unlimited access to the Helpline throughout the entire maintenance phase and continue 
to receive encouraging text and IVR messages. However, no new activities or concepts are 
initiated or introduced. 
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3 Objectives
The current study’s primary objective was to test the hypothesis that HE produces an 
increased long-term, i.e. 6 months, cessation rate in treatment seeking smokers, as compared 
to a control group receiving a self-help booklet (SHB). A plausible explanation for the 
hypothesized difference is that HE indeed mimics the qualities of cognitive-behavioural 
therapy, develops self-regulatory capacity, and offers instant relapse prevention. Moreover, 
the study investigated possible interaction effects between the experimental condition and 
several background variables, i.e. gender, age, education, and nicotine dependence, upon 
cessation outcome. Because HE is designed to assist anyone whom is a smoker and motivated 
to quit it was expected that few interaction effects would occur. Nevertheless, this had to be 
tested in order to know. 
The study also had several secondary objectives. First, the study tested the hypothesis that 
HE increases participant’s self-efficacy as compared to the SHB group. The reason to expect 
this is because HE includes preparing participants for expected difficulties, reminding the 
participants about their skills and their support system among other things. The study also 
tested the hypothesis that HE increases the extent to which smokers perform coping planning 
as compared to the SHB group. On the basis of including problem-solving tasks, reflecting, 
and specifying coping responses related to tempting or critical situations, it is expected that
HE increases coping planning as well.
Second, the study examined whether self-efficacy or coping planning mediates the effect 
of abstinence at 1 month separately. The HE program is designed to enhance both self-
efficacy and coping planning mainly during the 14-days preparation phase and 30-days action 
phase. This is one of the reasons why the point-measurement is narrowed down to 1 month 
post-cessation. The second reason is that any long-term mediation effects are expected to 
become attenuated as time passes and other variables come into play. 
Third, the study aimed at testing the difference in overall perceived usefulness and 
recommendation between the HE group and the SHB group at 3 months, shortly after the 
intensity of the HE programme is reduced to a minimum. Even though HE is likely to produce 
higher abstinence rates as compared to the SHB group, differences in overall perceived 
usefulness and recommendation cannot be expected in a natural setting.
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4 Methods
4.1    Interventions
The present study was conducted from February to September 2006. Enrolled participants 
were randomly assigned to one of two treatment conditions: the Internet- and mobile-based 
Happy Ending programme or the self-help booklet. Participants randomized to the 
experimental condition, that is Happy Ending, were registered with their email address and 
mobile phone number so the intervention would automatically start the preparation phase on 
the 20th of February. This means that the actual quit-date and initiation of the action phase 
would begin on the 6th of March. Participants randomized to the control condition received 
the booklet prior to the 20th of February, so as to be able to follow a 10-days program of 
preparation before quitting. All participants quit on the designated date (March the 6th, 2006).
Happy Ending. Happy Ending was originally established by Professor Pål Kraft at the 
University of Oslo and Harald Schjelderup-Lund. In the beginning, Happy Ending was 
supported by a professional advisory board including some of the leading researchers in 
Norway on smoking cessation. The programme was initially developed and designed for the 
Norwegian market in cooperation with the Norwegian Directorate for Health and Social 
Affairs and funded by The Research Council of Norway. Happy Ending has advanced and 
expanded since then. New versions of the programme have been released in both the U.S. and 
in Europe. Pharmaceutical companies licence the Happy Ending template and offer buyers of 
their smoking cessation products, programmes similar to Happy Ending as an adjunct. For 
more information in English please visit Pfizer’s U.S. programme GetQuit at 
http://www.chantix.com or their UK programme ActiveStop at http://www.nicorette.co.uk. 
For more information in Norwegian, go to visit http://www.happyending.no.
Self-help booklet. The self-help booklet Guide til Røykfrihet [Guide to Smokelessness] is 
issued by the Norwegian Directorate for Health and Social Affairs (2005) and only available 
in Norwegian. It contains 44 pages with a mixture of coloured images and text. During the 
initial pages the smoker is provided with information about why quit, how to quit, what 
beneficial bodily reactions to expect, nicotine replacement therapy, withdrawal symptoms, 
and relapse. The booklet encourages setting a quit date 10 days ahead. During the 10-days the 
smoker is preparing by being given small assignments each day (e.g. writing down reasons for 
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quitting, start smoking outdoors, no smoking the first 15 minutes after waking and last 15 
minutes before bedtime). The booklet contains a 10 days log-procedure to be used in this 
preparation phase. Here, smokers can fill out the number of cigarettes, the exact time of day 
for each cigarette, in what situations they were smoking, why they were smoking, and rate 
how well each cigarette tasted. There is also a 48 days quit calendar, a phone number to the 
Norwegian Directorate for Health and Social Affairs’ quitline, and links to relevant websites. 
Use of nicotine replacement therapy. In both treatment conditions, participants received 
information and recommendations about nicotine replacement therapy (NRT). Due to 
technicalities it was neither possible nor desirable to modify this aspect of the programme or 
the booklet. However, this study intended to evaluate the clean effect of Happy Ending as is 
without the use of NRT. Participants who wished to quit smoking without using NRT were 
actively recruited. Everyone was informed about this and agreed to attempt quitting without 
NRT. 
4.2    Sample Size and Recruitment
The expected quit rate at 6 months was 30% in the intervention group and 15% in the control 
group. The alpha level was set to .05 (one-sided). With 150 participants in each condition 
there was a 92% chance of detecting a significant main effect between treatments.
Participants were recruited online using banners and advertisements in A-pressen (for 
more information, see; http://www.apressen.no) which is a group of media companies 
producing local and regional newspapers throughout Norway. The recruitment campaign 
lasted from the 6th to the 10th of February in 2006. According to statistics from A-pressen the 
banners were displayed 947,059 times and resulted in 2,595 hits, which gives a hit-rate of 
0.27%. 
The banners and advertisements redirected potential participants to a website containing 
study information, a scheme for informed consent, and a baseline questionnaire. Persons who 
(a) were willing to quit on the 6th of March 2006, (b) were aged ≥ 18 years, (c) were currently 
smoking five cigarettes or more on a daily basis, (d) were willing to quit without using any 
kind of medicines or tobacco products, (e) owned a mobile phone, (f) had Norwegian 
registered phone number and postal mail address, and (g) had daily access to Internet and 
email, were eligible candidates for inclusion in the study. The final pool of participants 
contained 427 unique registered entrants within the given period. Note that all participants 
were self-selected.   
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4.3    Randomization
Table 1 presents the restricted randomization procedure which was applied (for overview, see; 
Shadish, Cook & Campbell, 2002). In addition to the condition, the pool of participants was 
divided into two categories; men/women, to assure an equal number of males and females. 
This yielded N ≈ 72 participants in each cell distributed across four cells based on the two 
dichotomous variables condition and gender. All eligible participants were assigned random 
numbers by computer-based random number generation. Finally, every fourth participant was 
allocated to each category in a pre-decided order based on their random allotted number. 
Table 1
Allocation of Participants (N = 290)
Gender TotalTreatment 
Condition Men Women
Happy Ending
Total      72            72                144
Self-Help Booklet      73            73         146
Total     145           145                290
One experimenter generated the allocation sequence and carried out the randomization 
procedure. A second experimenter registered and enrolled participants in the HE programme 
and sent the self-help booklets by postal mail service.
4.4    Blinding
Randomized control trials evaluating Internet-based interventions do not allow double-blind 
procedures to be carried out. Consequently, participants in the present study knew what 
treatment they received. However, they were not informed about their treatment assignment 
and what type of treatment other participants received. Neither was the experimenters blinded 
as e.g. registration and the nature of the surveys (i.e. exposure data) revealed which treatment 
condition the participants were assigned to. On the bright side, online-administered 
questionnaires with no face-to-face interactions between experimenters and participants help 
minimize biases introduced by humans (Eysenbach, 2002).
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4.5    Follow-Up Procedures
Pre-cessation data were collected at baseline and 3-days prior to cessation. More specifically, 
baseline refers to the time of enrolment before randomization and study onset. In contrast, 3-
days pre-cessation refers to after randomization and study onset. It corresponds to 11 days 
into the preparation phase in the programme, three days before the designated quit-date. Post-
cessation data were collected at 1, 3, and 6 months. 
An email containing a link to an online questionnaire was sent out to all participants at 
each measuring point. At 3-days pre-cessation, no further steps were employed to collect data. 
However, there was an extensive follow-up routine in the study to minimize attrition rates at 
1, 3, and 6 months. Participants had 1 week to complete the questionnaire. During the second 
week two email reminders were sent out to non-responders and in the third week telephone 
interviews were conducted with participants who still had not responded. The telephone 
interviews were structured and standardized following the email questionnaire with the 
exception of exposure data and programme evaluation which naturally differed according to 
treatment. There were four attempts to contact participants in both conditions over telephone 
at every data collection. 
Each data collection took three weeks to complete. The majority of responses (81%), 
however, were collected within the first week. There was no person-to-person counselling or 
face-to-face interaction between experimenters and participants at any point. However, 
participants were given the opportunity to pose questions regarding study accomplishments by 
email or telephone outside of the data collection. 
4.6    Measures
Regarding all psychological measures, reliability scores were calculated to account for the 
psychometric properties and a two-way translation, i.e. translation – back translation 
procedure, was used to assess the translation work and semantically verify the contents. For 
more information on the scales and measures, see appendix E.
Abstinence. Abstinence data were based on self-reports. Primary outcome was abstinence at 6 
months post cessation, defined as having been totally abstinent (not even a puff) for the last 7 
days. Secondary outcomes were abstinence at 1 and 3 months post cessation. Participants with 
missing values on smoking status were coded as daily smokers. 
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Demographics. At baseline, participants reported postal address, mobile phone number, email 
address, gender, age, education, and whether they had daily access to the Internet. In addition, 
several smoking related questions were asked to assess smoking and quit history (e.g. ‘What 
was your age when you began smoking on a daily basis?’). 
Programme evaluation. From the preparation phase and onwards, participants evaluated the 
programme (‘To what degree would you recommend Happy Ending/Guide til Røykfrihet to 
others that would like to quit smoking?’; ‘How useful do you think Happy Ending/Guide til 
Røykfrihet has been so far?’). Programme recommendation was rated on a 5-point scale from 
1 (not at all) to 5 (to a very high degree) while programme usefulness was rated on a 5-point 
scale from 1 (completely useless) to 5 (very useful).  
Psychological measures. Nicotine dependence was assessed by the use of the revised 
Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker & 
Fagerström, 1991). The FTND is a widely used six-item self-report measure (e.g. ‘How soon 
after you wake up do you smoke your first cigarette?’). According to Heatherton et al. (1991), 
the revised FTND has an internal consistency of .61. In the current study the Cronbach alpha 
coefficient was .68. 
The Self-Efficacy scale (SE; Ajzen, 2002a; 2002b) is a two-item scale which corresponds 
to the perceived behavioural control dimension in the theory of planned behaviour (TpB). The 
items are constructed in line with the recommendations in the TpB (Ajzen, 2002a) and were 
measured both pre- and post-cessation. Both control belief strength (‘I will manage to quit 
smoking’) and control belief power (‘To quit smoking for good will be...’) was assessed. 
Statements were evaluated on a 7-point scale and the Cronbach alpha coefficient was .82 in 
the current study. 
The Coping Planning scale (CP; Sniehotta et al. 2005) is a nine-item scale originally used 
in relation to physical exercise. Coping planning refers to behavioural and cognitive strategies 
used to link anticipated barriers and suitable responses. The scale in this study was adapted to 
smoking cessation and cut down to five items rated on a 4-point scale ranging from 1 
(completely disagree) to 4 (completely agree). Respondents indicate to what degree a 
statement reflects how detailed plans they have made for suitable coping responses (e.g. ‘… 
when I have to pay extra attention to prevent lapses’). In the Sniehotta et al. study the CP 
scale had an internal consistency of .90. In the current study the scale had a Cronbach alpha 
coefficient of .86. 
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4.7    Statistical Methods
An alpha level of .05 was chosen for all statistical tests and, unless otherwise specified, all 
tests were two-tailed. All continuous psychological scores were mean-centered (mc) with an 
exception for the baseline sample characteristics. To check for differences between 
experimental conditions at baseline, t-tests were employed for scales while χ² tests were 
performed for categorical data. Furthermore, all χ² tests that were based on 2 by 2 contingency 
tables applied the Yates’ continuity correction. Outcomes were examined using the intent-to-
treat (ITT) principle, i.e. abstinence rates were based on all participants who were included in 
the study after randomization. All participants who withdrew from the study or did not answer 
the abstinence questions were classified as smokers. 
For each of the three post cessation abstinence measure points, the odds ratio (OR) with 
the 95% confidence interval (CI) and a χ² test for experimental condition was carried out to 
detect a main treatment effect. In order to examine the importance of background variables 
and experimental condition on abstinence, the block χ2 in hierarchical logistic regression was 
compared to the overall -2 Log Likelihood (-2LL) to assess increases in explained variance. 
A one-way between-groups analysis of variance was conducted to examine the impact of 
experimental condition on levels of self-efficacy and coping planning at 3-days pre-cessation 
separately. The eta squared for one-way between-groups analysis of variance was used to 
calculate the effect size.
In order to test mediation effects in logistic regression, two conditions must be met. The 
first condition is that the mediating variables should contribute to the equation. This entails a 
hierarchical logistic regression procedure to test if a subset variable makes a significant 
contribution to the model. Thus, experimental condition was entered in step one and 3-days 
pre-cessation self-efficacymc and 3-days pre-cessation coping planningmc respectively in step 
two. Second, a reduction in the effects of the experimental condition should be evident after 
entering the subset variables. The experimental condition at step one should either become 
statistically non-significant or less significant in step two when the mediating variables are 
entered. If these two conditions are met, a mediating effect is established. 
Finally, t-tests were employed to evaluate differences in overall perceived program 
usefulness and program recommendation at 3 months. The eta squared for independent-
samples t-tests was carried out to calculate effect sizes while descriptives were applied to 
explore component ratings and the use of components at 1 month.
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5 Results
The flow chart of participants (from; Altman et al., 2001) is depicted in figure A1, appendix 
A. A total of 427 participants were eligible of which 131 participants were excluded. Twenty-
three did not meet the inclusion criteria, 6 had an invalid email address, 1 reported being 
signed up for the study by a person other than himself, and 19 were suspected to know each 
other. The latter were excluded to reduce the risk of communication across experimental 
conditions. This was done based on sharing or having the same family name, postal address, 
email address, mobile phone number, IP-address, and worksite. Furthermore, participants (N
= 82) with missing values on important variables (e.g. gender) or missing values on several 
items were also excluded from the pool. None of the 296 eligible entrants had missing values 
on more than one item which was imputed by the item sample means. Six participants out of 
296 were excluded after study onset because they did not fulfil the inclusion criteria. Four 
participants had quit smoking two weeks prior to the intervention, one participant had been 
signed up by another person without consent, and one participant gave away his or her 
position without giving notice. Consequently, the final number submitted for analysis was 
290, i.e. 144 in the HE group and 146 in the control group.
Insert Figure A1 about here,
see Appendix A
5.1    Baseline Data and Response Rates
Baseline sample characteristics are represented in table 2. Independent-samples t-tests and χ2 
tests were conducted to evaluate the baseline characteristics between conditions. There were 
no variables on which treatment and control participants differed significantly which supports 
the validity of follow-up outcomes. 
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Table 2
Baseline Sample Characteristics by Condition (N = 290)
   Treatment         Control
     n = 144         n = 146
   Gender
      Male      72 (50.0)       73 (50.0)
      Female      72 (50.0)       73 (50.0)
   Education
      0-9 years       9 (6.3)         13 (8.9)
      10-12 years      65 (45.1)         57 (39.0)
      13-15 years      43 (29.9)         50 (34.2)
      16 + years        27 (18.8)         26 (17.8)
   Age   39.5 ± 11.0      39.7 ± 10.8
   Age at smoking onset              16.2 ± 2.8      15.9 ± 2.8
   FTND     4.5 ± 2.3        4.6 ± 2.2
   Pre-cessation self-efficacy       5.1 ± 1.4        5.1 ± 1.3
   Coping Planning     2.3 ± 0.6        2.4 ± 0.7
Note. Numbers represent mean ± standard deviation for continuous variables and number of 
observations with percentage of observations in parenthesis, respectively.
The proportion of participants responding to the online questionnaires were 91%, 85%, 
79%, and 68% for 3-days pre-cessation, 1, 3, and 6 months post-cessation respectively. A 
pattern of descending response rates over time was evident. Furthermore, total response rates 
after the complete follow-up procedure were 91%, 92%, 92%, and 84% for 3-days pre-
cessation, 1, 3, and 6 months post-cessation respectively. The average response rate (after 
email reminders and telephone interviews) was 92% in the experimental group and 87% in the 
control group. While a larger proportion of participants in the experimental group (N = 124; 
86%) responded than control participants (N = 120; 82%) at 6 months follow-up, the 
difference in attrition rates [χ2 (1) = 0.57, p = .45] did not reach statistical significance. 
Between-groups differences in attrition rates were statistically non-significant at 3-days pre-
cessation [χ2 (1) = 0.13, p = .71] and 3 months post-cessation [χ2 (1) = 1.06, p = .30]. 12 (4%) 
and 15 (5%) were missing at 3-days pre-cessation and 9 (3%) and 15 (5%) were missing at 3 
months in the HE and SHB group respectively. However, the between-groups difference in 
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attrition rates at 1 month was statistically significant [χ2 (1) = 7.48, p = .006]. 19 (13%) 
respondents were missing in the control group while 5 (3.5%) were missing in the 
experimental group. Hence, selective attrition may have compromised the results at 1 month. 
5.2    Abstinence
Table 3 presents 1, 3, and 6 months cessation outcomes by treatment condition. The primary 6 
months ITT analysis found a statistically significant 7-days abstinence rate among participants 
assigned to HE [χ2 (1) = 9.42, p = .002; OR = 2.59, 95% CI: 1.43 - 4.69] compared to the 
SHB. Statistically significant differences between HE and SHB were also present at 1 [χ2 (1) 
= 19.91, p < .001; OR = 3.46, 95% CI: 2.01 - 5.95] and 3 months [χ2 (1) = 13.73, p < .001; OR 
= 2.93, 95% CI: 1.67 - 5.14]. The results demonstrate that the treatment effect was consistent 
over time. The odds ratios decreased from 1 month to 6 months, but the confidence intervals 
were predominantly overlapping. 
Table 3
Comparison of Abstinence Rates Between HE and the SHB (N = 290)
HE SHB
Abstinence rates N % N % OR 95% CI 
of ORs
P-value
7-days abstinence at 1 month 60 41.7 25 17.1 3.46 2.01-5.95 .000*
7 days abstinence at 3 months 51 36.8 23 15.8 2.93 1.67-5.14 .000*
7 days abstinence at 6 months 42 29.2 20 13.7 2.59 1.43-4.69 .002
Note. *p < .0005.
As previously mentioned, this study was set to assess the clean effect of the HE 
programme without the use of NRT. In spite of this, many participants chose to use NRT 
which is most likely a consequence of the recommendations about NRT in both HE and the 
SHB. At 6 months 17 (8%) participants in the HE group and 9 (4%) participants in the SHB 
group reported having used NRT during the last 7 days. The difference in NRT usage [χ2 (1) = 
1.60, p = .21] was statistically non-significant suggesting that differences in NRT usage did 
not compromise the results at 6 months. An additional analysis was carried out excluding 
those who reported using NRT during the last 7 days and those who had a missing value on 
the item at 6 months. The total number of participants submitted for analysis was 198. 
Overall, a statistically significant difference of HE compared to the SHB prevailed [χ2 (1) = 
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4.78, p = .03; OR = 2.26, 95% CI: 1.14 - 4.48], indicating that HE was effective without the 
adjunct of NRT.
5.3    Interaction Effects
Hierarchical logistic regression was used to test for interaction effects between HE and 
several background variables. The number of participants included in each analysis was 290. 
No interaction effects appeared for age, education or nicotine dependence. However, there 
was a significant increase in explained variance for gender [block χ² (1) = 4.00, p = .05; OR = 
3.47, 95% CI: 1.00 - 12.09].  More specifically, males in HE had statistically significant 
higher abstinence rates as compared to the SHB group at 6 months (B = 1.66, p = .001; OR = 
5.24, 95% CI: 1.99 - 13.84). There was no such effect among females in HE as compared to 
the SHB group upon abstinence (B = 0.41, p = .30; OR = 1.51, 95% CI: 0.70 - 3.31). 
5.4    Between-Groups Differences in Self-Efficacy and Coping Planning                                                         
A one-way between-groups analysis of variance was conducted to explore the impact of 
experimental condition on levels of self-efficacy at 3-days pre-cessation. There was a 
statistically significant difference in self-efficacy scores between HE (M = 5.48, SD = 1.23) 
and the control condition [M = 5.08, SD = 1.26; F(1, 261) = 6.94, p = .009]. Despite reaching 
statistical significance, the actual difference in mean scores between groups was small. The 
effect size, calculated using eta squared, was 0.03 which means only 3% of the explained 
variance in 3-days pre-cessation self-efficacy could be accounted for by the experimental 
condition.
Similarly, a one-way between-groups analysis of variance was conducted to explore the 
impact of experimental condition on levels of coping planning at 3-days pre-cessation. There 
was a statistically significant difference in coping planning between HE (M = 3.00, SD = 0.53) 
and the control condition [M = 2.80, SD = 0.52; F(1, 261) = 9.4, p = .002]. The estimated effect 
size, using eta squared, was 0.03 which means only 3% of the explained variance in 3-days 
pre-cessation coping planning could be accounted for by the experimental condition. Overall, 
HE enhances self-efficacy and coping planning levels, but to a small magnitude. 
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5.5    Mediation
In order to test for mediation, experimental condition was entered in step one and 3-days pre-
cessation self-efficacymc was entered into a hierarchical logistic regression in step two. Table 
B4.1, in appendix B.01, presents the results from the mediation analysis. There was a 
statistically significant improvement in block χ2 (1) = 18.45, p < .000, between step one and 
step two, supporting the first condition for mediation. Also, an increase in the measures of the 
predictive efficacy of the logistic regression was achieved when self-efficacymc was included in 
the model. The increase was evident in RN
2 and in the percentage of cases correctly predicted 
(68.4% vs. 71.5%). The second condition for mediation is a reduction in the explanatory power 
of the experimental condition after the inclusion of self-efficacymc. The result did show that the 
experimental condition had a lower coefficient in step two, but it was still statistically 
significant at the same p-value (B = 1.08, p < .000). The finding meets the first condition for 
mediation in logistic regression, but not the second condition as is required. Hence, 3-days pre-
cessation self-efficacymc did not mediate the effect of the experimental condition on abstinence 
at 1 month. 
Insert Table B5.1 about here, 
see Appendix B.01
Table C5.1 in appendix C.01 presents the results of the test for mediation between 
experimental condition, 3-days pre-cessation coping planningmc, and abstinence at 1 month. A 
statistically significant improvement in block χ2 (1) = 5.25, p = .02, between step one and step 
two was achieved, supporting the first condition for mediation. There was an increase in RN
2, 
but a slight decrease in the predictive efficacy from 68.4% to 68.1% when coping planningmc
was entered into the model. The result also shows that the experimental condition has a lower 
coefficient in step two, but the experimental condition is still statistically significant at the 
same p-value (B = 1.10, p < .000) as in model 1. Thus, the finding does not support the 
second condition for mediation in logistic regression. 
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Insert Table C5.1 about here, 
see Appendix C.01
5.6    Programme Evaluation
There was a statistically significant difference in perceived usefulness of HE (M = 3.37, SD = 
1.45) as compared to the SHB [M = 2.59, SD = 1.22; t(245) = (-4.57), p < .000] at 3 months. 
However, the effect size of the differences in the means was very small (eta squared = 0.08). 
Expressed as percentages, 8.0% of the variance in perceived usefulness of the programme was 
explained by the experimental condition. Even though there was a difference in the perceived 
usefulness of the treatments, the degree to which participants would recommend HE (M = 
3.00, SD = 1.47) to others as compared to the SHB [M = 2.85, SD = 1.30; t(248) = (-0.85), p = 
.40] was statistically non-significant at 3 months. 
In addition, participants rated the perceived usefulness of the different programme 
components in HE at 1 month. Presented in descending order, the components are ranked 
from the most useful to the least useful; the log-off procedure (M = 3.40, SD = 1.51), text 
messages (M = 3.27, SD = 1.44), log-on procedure (M = 3.26, SD = 1.53), interactive diary (M
= 2.95, SD = 1.37), relapse prevention system (M = 2.84, SD = 1.48), and the Helpline (M = 
2.39, SD = 1.25). Less than 5% of the participants in HE reported they had never used the log-
off procedure, text messages, log-on procedure, and interactive diary suggesting a high utility 
rate. However, approximately one fourth reported they had never used the Helpline or the 
relapse prevention system suggesting less than optimal compliance. 
5.7    Adverse Effects
About 10 participants reported in open-ended questions that HE was too intensive, in the 
sense that it interfered with work and personal life. They used descriptions like “annoying”, 
“bothersome”, and “stressful”. These remarks might suggest that HE can potentially be 
inappropriate for a smaller group of certain smokers which for example have night- and shift 
work. Other than that, no remarks were made about any negative experiences or consequences 
of HE. 
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6 Discussion
6.1    Synopsis
This trial demonstrated the efficacy of the Internet-, mobile phone-, and IVR-based smoking 
cessation programme HE over the SHB. The efficacy persisted when removing the effect of 
NRT. The treatment effect was consistent across sample subgroups defined by age, education, 
and nicotine dependence. However, males benefited more from HE when compared to the 
SHB group. No such effect was observed for females. In addition, HE managed to increase 
levels of self-efficacy and coping planning, but neither mediated the relationship between the 
experimental condition and abstinence. Overall, HE was perceived somewhat more useful 
than the SHB, although participants would not recommend HE to others more than 
participants would recommend the booklet. Most participants utilized the programme 
components in HE, but approximately one fourth did not use the Helpline or relapse 
prevention system. 
6.2    Interpretation of the Results
Abstinence. Most ICT-based smoking cessation interventions are randomized trials, apply the 
ITT analysis, use similar statistical methods, and online recruitment procedures (Cobb, 
Graham, Bock, Papandonatos & Abrams, 2005; Etter, 2005; Feil, Noell, Lichtenstein, Boles 
& McKay, 2003; Lenert et al. 2003; Munoz et al., 2006; Rodgers et al., 2005; Stoddard et al., 
2005; Strecher et al., 2005; Swartz et al., 2006). However, few assess long-term outcomes, 
many apply different recruitment strategies (e.g. stage-based vs. treatment seeking smokers), 
different operationalizations for measures of abstinence (e.g. point-prevalence vs. continuous 
abstinence) and many have unequal lengths and procedures for follow-up which all cause 
problems of interpretation (for a discussion, see; West, Hajek, Stead & Stapleton, 2005). 
Evidently, even different recruitment strategies will result in widely different samples which 
make no sense to compare abstinence rates. Similar problems apply when extending and 
comparing the findings with other types of smoking cessation interventions. Thus, it becomes 
necessary to compare effect sizes, i.e. the odds ratios and their corresponding confidence 
intervals.
Figure D2 in appendix D depicts the odds ratios with 95% confidence intervals for the 
different studies and types of interventions compared next. The comparison of ICT-based 
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interventions is restricted to digitally-delivered and fully automated interventions which are 
the most similar to HE. There are three previous trials (Rodgers et al., 2005; Strecher et al., 
2005; Swartz et al., 2006) which have demonstrated an effect for up to 3 months post-
cessation. The study by Rodgers et al. used relative risk, as opposed to odds ratio, which 
complicates direct comparison. Nevertheless, it is emphasized that they did not find a long-
term effect, but merely a 6 weeks effect. The long-term effect (6 months) of the present study 
as compared to the 3 months effect in the Strecher et al. study is higher with a barely 
overlapping lower limit of the CI. The only study with a comparable effect was carried out by 
Swartz et al. They attained a slightly higher OR at 3 months, but the CI is even wider than in 
the present study.
Insert Figure D2 about here,
see Appendix D
In terms of the OR, the long-term effect of HE outperforms the long-term effects of a 
variety of self-help interventions including social support (May, West, Hajek, McEwen & 
McRobbie, 2006; see also; May & West, 2000), telephone counselling (Stead, Perera & 
Lancaster, 2006), and different forms of tailored self-help materials, i.e. written materials, 
audio-, and videotapes (Lancaster & Stead, 2005a). The lower limit CI in the current trial is 
only slightly overlapping with the upper limits for telephone counselling and tailored self-help 
materials. When compared to the pooled effects of individual behavioural counselling 
(Lancaster & Stead, 2005b) and group behavioural therapy (Stead & Lancaster, 2005), HE has 
a higher long-term OR. However, the lower limit of the CI does overlap with both individual 
behavioural counselling and group behavioural therapy although the upper limit is 
considerably higher in HE. Finally, compared to the pooled effect of different forms of NRT, 
i.e. gum, patch, nasal spray, inhaler, and sublingual tablet, the long-term OR in HE is higher 
(Silagy et al., 2004). The CI for HE even consumes the entire treatment effect of NRT. 
Clearly, the comparisons favour the HE programme as an efficacious ICT-based smoking 
cessation treatment although the CI is considered to be wide. Information and communication 
technology provides a new channel for delivering smoking cessation interventions 
inexpensively, conveniently and irrespective of location without requiring human labour – an 
argument often advocated in research on Internet interventions (Strecher, 2007; Swartz et al., 
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2006). This trial makes a significant contribution to the promise of digitally delivered and 
fully automated interventions. It is, to the best of our knowledge, the first trial to document a 
long-term effect and to provide a thorough description of the theoretical foundation. 
The gender effect. HE had a greater effect on males than on females which reflects the 
traceable effect of gender in smoking cessation outcome (Wetter et al., 1999; for examples, 
see; Carlson, Goodey, Bennett, Taenzer & Koopmans, 2002; Perkins, Donny & Caggiula, 
1999). Gender by itself is not a meaningful theoretical or clinical explanatory factor, but 
requires examining the association of gender and abstinence in conjunction with other 
variables (Wetter et al., 1999). Collins et al. (2004) has argued that women are more likely 
than men to manage negative affect by smoking. Indeed, bupropion which is an antidepressant 
with demonstrated effectiveness in smoking cessation (Hughes, Stead & Lancaster, 2007; 
Jorenby et al., 1999) has evidenced to erase the effect of gender on relapse (Gonzalez et al., 
2002). HE addresses negative affect, but this study was not set to empirically examine this 
relationship. However, negative affect may theoretically help explain the observed effect of 
gender on cessation outcome. 
Between-groups differences. The results showed that HE increases levels of both self-
efficacy and coping planning although only to a small extent. A plausible reason for the small 
effect could be that only 11 days had passed since programme initiation. More importantly, 
this study managed to document changes in psychological constructs related to an ICT-based 
intervention. Most ICT-based smoking cessation research focus on investigating smoking 
cessation outcome, use of incentives on attrition rates, testing online questionnaires vs. paper-
and-pencil methods, etc. (for examples, see; Feil et al., 2003; Lenert et al., 2003; Stoddard et 
al., 2005). None of these studies explicitly trace and document any psychological constructs. 
In order to improve ICT-based interventions, it becomes necessary to find exactly what 
constructs (e.g. self-efficacy) are associated with positive outcomes. It cannot be taken for 
granted that the active ingredients are the same online as off-line. 
Mediation. The effect of the between-groups analyses of self-efficacy and coping planning 
suggested a mediation effect would be small. And as the first condition for mediation was 
confirmed while the second condition failed to support mediation, the occurrence of a type II 
error cannot be ruled out. The sample size required to detect medium effect sizes with linear 
mediational models is relatively large (> 500; MacKinnon, Lockwood, Hoffman, West and 
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Sheets, 2002) and similar sample sizes for adequate estimations in logistic mediational models 
has been suggested (Huang, Sivaganesan, Succop & Goodman, 2004). Another explanation 
can be that selective attrition at 1 month may have compromised the detection of mediation. 
However, as both self-efficacy and coping planning are immanent in all participants, as 
opposed to abstinence, mediation should be less affected by attrition rates. One last 
explanation may actually assume a theoretical basis. Sayette (2004) has suggested that many 
quitters manage to perform appropriate and learned coping responses when temptations are 
low to moderate. However, when temptations become strong, a loss of cognitive control 
makes quitters unable to apply specified coping responses which results in self-regulatory 
failure. Several studies support the reasoning provided by Sayette (2004) which seems to 
apply to self-efficacy as well (for examples, see; Bliss, Garvey & Ward, 1999; Gwaltney, 
Shiffman & Sayette, 2005; Sayette & Hufford, 1994; Tiffany, 1990; Gwaltney, Shiffman, 
Balabanis et al., 2005; Shiffman, Paty et al., 1996). Consequently, in vivo skills training is 
suggested, before making the actual quit attempt, to improve implementation of appropriate 
coping responses during strong temptations (Sayette, 2004). In short, in vivo skills training 
entails e.g. performing coping planning during longer periods of deprivation since last 
cigarette.
Programme utility. Although the perceived usefulness of HE was assessed, the fact that as 
much as one fourth reported they had never used two of the components highlights an issue 
which needs to be discussed. It may be tempting to interpret non-utility as an indication of 
low compliance, but several other explanations might account for the lack of use (e.g. 
technological barriers or difficulties understanding instructions). ICT-based interventions find 
themselves at the intercept between human-computer interactions, and should seriously take 
into consideration the psychological aspects of human use of computing (for overview, see; 
Olson & Olson, 2003). For example, most smoking cessation websites are not available in 
alternative formats which decreases accessibility (e.g. for people with reduced sight; Bock et 
al. 2004). According to the Norwegian Association of the Blind and Partially Sighted (2007), 
Norway has 130,000 persons with reduced sight to such a degree that they are considered 
visually impaired. Obviously, this excludes not just participants from participating in 
research, but perhaps more seriously it excludes research and smoking cessation interventions 
to aid the visually impaired.
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6.3    Limitations
Self-reported data. Abstinence was measured solely by self-reporting due to the geographical 
spread of the sample. However, self-reported data are generally accurate and does not require 
biochemical verification when samples are (a) population-based, (b) includes data collection 
by telephone or Internet, and (c) when there is low intensity, low frequency, and no face-to-
face contact between researcher and participant (Velicer, Prochaska, Rossi & Snow, 1992; 
Benowitz et al., 2002; Glasgow et al., 1993; Patrick et al., 1994). Neither did the sample 
consist of particular subgroups which warrant caution (e.g. adolescents; see; Attebring, 
Herlitz, Berndt, Karlsson & Hjalmarson, 2001; Caraballo, Giovino & Pechacek, 2004; Parna 
et al., 2005). 
Accessibility. There is a concern regarding the demographic disparity in access to the Internet 
for the age group 60 years and above. These potential participants belong to the group with 
the least access to the Internet (Tjøstheim, 1999; TNS Gallup, 2001) which might preclude 
sample representativeness and generalizability of findings. Otherwise, statistics for Norway 
indicate high accessibility to the Internet and mobile phones in the general population 
(Statistics Norway, 2006; TNS Gallup, 2001). Given a broad national ICT covering like in 
Norway, ICT-based interventions allow a wide geographical spread of the sample which is
actually a great strength as participants can be recruited literally from all over the world and 
further enhance generalizability.
Contamination. The relatively unaltered abstinence rate in the SHB group suggests
contamination. The suspicion was substantiated when inspecting the outliers in the data 
material, but which were included because of the ITT analyses. A vast majority of the outliers 
were found belonging to the SHB group. Considering that treatment seeking smokers are most 
likely to seek alternative treatment when a one approach fails, contamination becomes a fair 
concern. Especially when remembering that the booklet provides several useful tips on 
resources like the national quitline and a variety of websites. Also, remember that participants 
not interested in using NRT were actively recruited which adds truth towards the suspicion of 
contamination by other treatments than NRT. 
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6.4    Generalizability
Self-selection. The recruitment procedure in this trial was based on self-selection. 
Consequently, generalizations must be done with caution. There are two subgroups of 
smokers which might preclude representativeness. One is research volunteers and the other is 
treatment seeking smokers. Both have been found to differ from self-quitters in the general 
population on several characteristics (Hughes, Giovino, Klevens & Fiore, 1997) and they may 
be susceptible towards participation to receive free treatments (McClure et al., 2006). 
Furthermore, Cobb and Graham (2006) specifically attempted to characterize Internet users 
searching for smoking cessation information and found that more than half of the participants 
were motivated treatment seeking smokers planning to quit the next 30 days. This indicates 
that treatment seekers actively use the Internet to stop smoking and are likely to be research 
volunteers as well. Together, research volunteers and treatment seekers are most likely 
considerably more motivated to change the habit. Evidence of clearer benefits in subgroups of 
smokers motivated to quit has also been found previously (Stead et al., 2006). On the other 
hand, comparing participants in HE to other treatment seeking smokers, e.g. smokers that buy 
HE outside of the research context, is likely to provide a conservative treatment effect as it 
takes place in a natural setting. Thus, the natural setting imposes realism which enhances 
generalizability. 
Intent-to-treat. Data were analysed as if participants had received the full experimental 
treatment or only the control treatment. It is very strict to assume that every participant has 
adhered to the prescribed protocol (Gross & Fogg, 2004). Thus, the inclusion of participants 
with varying degrees of adherence mirrors real-world behaviour which enhances 
generalizability. It is also unreasonable to treat every non-responder as a smoker. There may 
be many trivial reasons why participants do not respond (e.g. blockage of emails due to spam 
filters, tight work schedules, changed phone number without giving notice). As such the 
intent-to-treat principle is likely to have provided a conservative estimate. In addition to the 
low attrition rates and significant treatment effect, there is every reason to be confident about 
the findings. 
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6.5    Conclusion
The study found the digitally delivered and fully automated smoking cessation programme 
Happy Ending to be an effective smoking cessation treatment. The randomized control trial 
and ITT analyses lend confidence to the findings as it reduces the plausibility of alternative 
explanations and provides conservative estimates. Additionally, the programme was in 
particular effective for males and documented increases in self-efficacy and coping planning
although no mediation was found. Happy Ending was perceived somewhat more useful than 
the self-help booklet while the Helpline and the relapse prevention system were not utilized to 
its full potential. The findings extend to online treatment seeking smokers with some 
uncertainty regarding elderly aged 60 years and above. 
Considering that modest increases in smoking cessation are likely to have practical and 
clinical significance, smoking cessation is likely to have substantial effects on mortality and 
morbidity. It has been estimated that an effect of as little as 1% on 6 months continuous 
abstinence would result in at least 3 years of additional years of life for every 100 40-year-old 
smoker treated (West, 2007). Imagining that HE produced a 6 months continuous abstinence 
rate, given the current results, a 29% continuous abstinence rate would save 87 years of life 
per 100 smokers treated. Even though treating a smoker with Happy Ending costs 1500,-
NOK and many smokers will need more than one treatment, the price required for successful 
cessation quickly fades. Over and above personal health, the implications of smoking 
cessation are among other things associated with lower health care expenses, increased work 
productivity, and decreased absenteeism (Fiore, Hatsukami & Baker, 2002). Thus, Happy 
Ending and other ICT-based smoking cessation programmes which offer relatively high-
reach, high-efficacy, and low-cost population-based treatments can effectively help people 
and society to suppress the epidemic of our modern times.
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APPENDIX A
Figure A1 
The Flow Chart of Participants (from Altman et al., 2001) 
Note. Post cessation data were collected for participants that discontinued the intervention.
Assessed for eligibility
(n=427)
Enrollment
Restricted stratified 
randomization (n=296)
Excluded (n=131)
Did not meet inclusion criteria 
(n=23)
Refused to participate (n=0)
Other reasons (n=108)
Allocated to Happy Ending 
(n=148)
Received allocated intervention 
(n=144)
Did not receive allocated 
intervention (n=4)
3 participants quit prior to 
intervention & 1 participant gave 
away his position.
Allocated to self-help booklet 
(n=148)
Received allocated intervention 
(n=146)
Did not receive allocated 
intervention (n=2)
1 participant quit prior to 
intervention & 1 false enrolment.
Allocation
Lost to follow-up {Cumulative}:
1m (n=1)
3m (n=2) {3}
6m (n=4) {7}
Discontinued intervention:
1m (n=2)
3m (n=0) {2}
6m (n=3) {5}
Lost to follow-up {Cumulative}: 
1m (n=0)
3m (n=1) {1}
6m (n=3) {4}
Discontinued intervention: 
(n=0)
Follow-up
Analyzed (n=144)
Excluded from analysis (n=0)
Analyzed (n=146)
Excluded from analysis (n=0)
Analysis
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APPENDIX B
B.01  Table B4.1
The Relationship between Experimental Condition, 3-Days Pre-Cessation Self-Efficacy, and 
Abstinence at 1 Month (N = 263)
Predictor Model 1 Model 2
Constant -1.45** -1.47**
Experimental condition 1.20** 1.08**
Self-efficacymc 0.53**
Model χ2 19.21** 37.65**
Degrees of freedom 1 2
Block χ2 18.45**
Degrees of freedom 1
Percent correctly predicted 68.4 71.5
Cox & Snell R2 0.07 0.13
Nagelkerke R2 0.10 0.19
Note. B-values are given for predictors. Experimental condition coded as 0 = self-help 
booklet, 1 = Happy Ending. χ2 (8) = 3.95, p = .86 (Hosmer & Lemeshow). -2LL = 290.31. ** 
p < .001. 
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B.02  Table B4.2
Intercorrelations for the Relationship between Experimental Condition, 3-Days Pre-
Cessation Self-Efficacy, and Abstinence at 1 month (N = 263)
Measure 1 2 3
1. Abstinence --
2. Experimental condition .270** --
3. Self-efficacymc .304* .268 --
Note. Abstinence coded as 0 = smoker, 1 = abstinent. Experimental condition coded as 0 = 
self-help booklet, 1 = Happy Ending. Φ correlation coefficient calculated between nominal 
variables. η correlation coefficient calculated between nominal and interval variables. *p < 
.05. **p < .001.
B.03  Table B4.3
Mean Values and Frequencies for Measures as a Function of Abstinence at 1 Month (N = 
263)
Smoker Abstinent
Measure (N = 205) (N = 85) χ2(1) or t(213)
Experimental condition (%) 41 71 19.90*
Pre-cessation self-efficacymc -0.24 0.53 -5.36*
Note. Experimental condition coded as 0 = self-help booklet, 1 = Happy Ending. χ2 test used 
between categorical measures; t-test used for other measures. *p < .001. 
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APPENDIX C
C.01  Table C5.1
The Relationship between Experimental Condition, 3-Days Pre-Cessation Coping Planning, 
and Abstinence at 1 Month (N = 263)
Predictor Model 1 Model 2
Constant -1.45** -1.41**
Experimental condition 1.20** 1.10**
Coping planningmc 0.62*
Model χ2 19.21** 24.46**
Degrees of freedom 1 2
Block χ2 5.25*
Degrees of freedom 1
Percent correctly predicted 68.4 68.1
Cox & Snell R2 0.07 0.08
Nagelkerke R2 0.10 0.13
Note. B-values are given for predictors. Experimental condition coded as 0 = self-help 
booklet, 1 = Happy Ending. χ2 (8) = 13.80, p = .09 (Hosmer & Lemeshow). -2LL = 303.51. *p 
< .05. **p < .001.  
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C.02  Table C5.2
Intercorrelations for the Relationship between Experimental Condition, 3-Days Pre-
Cessation Coping Planning, and Abstinence at 1 Month (N = 263)
Measure 1 2 3
1. Abstinence --
2. Experimental condition .270** --
3. Coping planningmc .330 .374* --
Note. Abstinence coded as 0 = smoker, 1 = abstinent. Experimental condition coded as 0 = 
self-help booklet, 1 = Happy Ending. Φ correlation coefficient calculated between nominal 
variables. η correlation coefficient calculated between nominal and interval variables. *p .05. 
**p < .001.
C.03  Table C5.3
Mean Values and Frequencies for Measures as a Function of Abstinence at 1 Month (N = 
263)
Smoker Abstinent
Measure (N = 205) (N = 85) χ2(1) or t(261)
Experimental condition (%) 41 71 19.90*
Pre-cessation coping planningmc -0.07 0.14 -3.00*
Note. Experimental condition coded as 0 = self-help booklet, 1 = Happy Ending. χ2 test used 
between categorical measures; t-test used for other measures. *p < .01. 
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APPENDIX D
Figure D2
Comparison of Treatment Effects across Different Studies and Types of Interventions
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APPENDIX E
Scales and Measures 
Abstinence og bruk av nikotinerstatningsprodukter:
1. Tenk på de siste 7 dagene. Hvor mange sigaretter har du røykt i løpet av disse dagene? 
Velg det svaralternativet som passer best for deg. 
a) Jeg har ikke en gang tatt ett trekk av en sigarett
b) Jeg har røykt av og til
c) Jeg har røykt daglig
2. Har du brukt nikotinerstatningsprodukter i løpet av de siste sju dagene?
Ja____ Nei____
Programevaluering:
3. Hvor nyttig synes du disse elementene i Happy Ending har vært for deg i slutteforsøket?
a) Sluttedagboka b) Røykesugtelefonen
c) Pålogging om morgenen d) Avlogging om kvelden
e) Terapi ved glipp f) SMS meldinger
Svar kategorier: 1 = helt unyttig - 5 = svært nyttig – 6 = har ikke brukt denne
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The Revised Fagerström Test for Nicotine Dependence (FTND):
4. Hvor lang tid etter at du våkner om morgenen tenner du din første sigarett?
a) Over en time etter____ b) 31-60 minutter____
c) 6-30 minutter____ d) Mindre enn 5 minutter etter____
5. Hvilken sigarett er vanskeligst å unnvære; er det den første om morgenen eller er det en 
senere på dagen?
a) En senere på dagen____ b) Morgens første____
6. Har du problemer med å la være å røyke på steder der røyking er forbudt?
Ja____ Nei____
7. Hvor mange sigaretter røyker du gjennomsnittlig per dag? Oppgi kun ett antall (dvs. ikke 
oppgi et intervall). ____
8. Røyker du dersom du er så syk at du er sengeliggende mesteparten av dagen?
Ja____ Nei____
9. Røyker du mer om morgenen enn senere på dagen?
Ja____ Nei____
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Self-efficacy (SE):
10. Vurder følgende påstander:
a) Jeg kommer til å klare å slutte å røyke
b) For meg vil det å slutte å røyke være
Svar kategorier: 1 = svært usannsynlig – 7 = svært sannsynlig
Coping planning:
11. Vurder hvor godt disse fem påstandene passer for deg.
Jeg har lagt konkrete planer for ...
a) … hvilke situasjoner jeg bør unngå for ikke å bli fristet til å røyke
b) … hva jeg skal gjøre i vanskelige situasjoner slik at jeg ikke ”glipper”
c) … når jeg må være ekstra påpasselig for ikke å få en ”glipp”
d) … hvordan jeg skal mestre røykesuget hvis det kommer
e) … hva jeg skal gjøre hvis jeg får en ”glipp”
Svar kategorier: 1 = helt uenig - 4 = helt enig
